Researchers awarded vital funding to explore treatment to slow rare liver disease

LifeArc and PSC Support have jointly awarded £948,774 for new research into primary sclerosing cholangitis (PSC) – a rare disease where the body attacks its own liver, causing inflammation and scarring of the bile ducts. The national study, led by Dr Palak Trivedi at BHP founder-member the University of Birmingham, is called FAecal microbiota transplantation in … Continue reading “Researchers awarded vital funding to explore treatment to slow rare liver disease”